Authors


Vandana Aspen, PhD

Latest:

Patient Resistance in Eating Disorders

Why do patients with eating disorders resist treatment? How can the clinician address resistance?


Vanessa Torres-Llenza, MD

Latest:

7 Medical Illnesses That May Present as Anxiety

Beyond psychosocial implications of anxiety disorders, an array of physiological effects may ensue.


Vani Rao, MD

Latest:

Pharmacological Management of the Psychiatric Aspects of Traumatic Brain Injury

Traumatic brain injury (TBI) is a public health epidemic. Psychiatric symptoms after TBI are not just common, but also troublesome.


Vernon A. Rosario, MD, PhD

Latest:

Erotic and Psychological Identities

When people turn to mental health professionals about sexual problems-cyber or otherwise-how comfortable and informed are we?


Veronica Hackethal, MD

Latest:

Neurological and Psychiatric Effects of Dermatology Drugs

A review of systemic medications for dermatologic diseases describes a wide range of adverse events, which range from mild and reversible to permanent and potentially fatal.


Vicky Stergiopoulos, MD

Latest:

Shelter-Based Collaborative Mental Health Care for the Homeless

Homelessness rates in both Canada and the United States have increased dramatically over the past 10 years. Among the homeless, there is a high prevalence of mental illness and substance use disorders.


Victor G. Carrion, MD

Latest:

Treatment of Traumatic Stress Disorder in Children and Adolescents

The role of prevention of trauma and prevention of functional impairment after trauma is paramount, because this may disrupt the accumulated physiological and psychological effect of stressors in the individual.


Victor Schwartz, MD

Latest:

Stress Reactions to COVID-19

This video examines the differences between typical, non-pathological reactions to the stress induced by the COVID-19 pandemic and psychopathology (or mental illness).


Victoria Hendrick, MD

Latest:

Hormones for Perimenopausal and Postmenopausal Depression

Mood and well-being are believed to be regulated by mechanisms of estrogen and progesterone. How effective are they in the treatment of major and minor depression?


Vijaya Lakshmi Appareddy, MD

Latest:

Issues in Treating Patients With Intellectual Disabilities

Psychiatric disorders in persons with intellectual disabilities are typically more severe and more difficult to diagnose than in the general population. Clearly, those who diagnose ID and treat patients with this condition face a number of challenges.


Vikram Shah, MD, MBA

Latest:

Seeing the Forest Through the Fees: Earning Your Green Using the New, Confusing CPT Codes

E&M codes are more complicated to learn, but psychiatrists can now deservedly get paid more for treating their more complicated patients or for engaging in time-consuming activities. Here: a focus on codes 99212 to 99215.


Vilma Gabbay, MD

Latest:

The Neurochemistry of Pediatric Major Depressive Disorder

Major depressive disorder (MDD) in pediatric populations represents a significant public health concern. Rates of MDD rise dramatically in adolescence, with an estimated lifetime prevalence of 15% in adolescents aged 15 to 18.


Vincent E. Krasevic, MD

Latest:

A Partnership of Increasing Significance

The role of psychiatry in primary care is an area of rapid expansion and increasing significance. Given the fact that inadequate diagnosis and treatment of psychiatric disorders are major public health problems, it is essential to integrate psychiatrists into multidisciplinary primary care teams. Since primary care physicians are increasingly called upon to act as "gatekeepers" in managed care programs, they will have to meet the important and growing need for broader psychiatric diagnostic and referral skills.


Vishal Madaan, MD

Latest:

Mini Quiz: Cognitive Enhancers

Which pharmacotherapeutic approach is most effective for cognitive enhancement? Test your knowledge with this quiz.


Vishesh Agarwal, MD

Latest:

Art Therapy in a Patient With Bipolar Disorder: Pictures Speak More Than a Thousand Words

Here: the case of a woman with bipolar disorder who was admitted for aggressive behavior and nonadherence to medications. Art therapy and pharmacotherapy played a pivotal role in her recovery.


Vivek Anand, MD

Latest:

Research That Can Change Clinical Practice in Psychotic Disorders

The need to stay up-to-date with the most current evidence-based information is becoming harder than ever. For this reason, the authors identify and evaluate published research that may have a direct bearing on clinical practice.



Vivien Chan, MD

Latest:

Managing the Suicidal College Student: Advice for Community Providers

Although college students are in many ways similar to any patient in their age group, their environment and stressors differ in significant ways. The authors identify issues to consider in assessing and managing suicidality in this population.


Vivien K. Burt, MD, PhD

Latest:

Psychiatric Disorders During Pregnancy

Treatment with psychopharmaceuticals may prove problematic for pregnant women. The decision to discontinue medications or to adjust dosages to minimize the risk to the fetus has to be addressed. The dynamic balance of treatment options, maternal concerns and practitioner responsibility depends upon staying abreast of the latest research in psychopharmacology and pregnancy.


Vladimir Khalafian, MD

Latest:

Shadows on a Wall: Phenomenology in an Acute Care Setting

We present the case of a patient for whom different attending providers had markedly different interpretations. As the case unfolds, we invite you to reflect on your diagnostic understanding of each presentation.


Vladimir Maletic, MD

Latest:

Key Takeaways for Treatment of Bipolar 1 Disorder

Andrew Cutler, MD, shares his key takeaway advice to psychiatrists for the diagnosis and treatment of patients with bipolar 1 disorder.


Vural Ozdemir, MD, PhD

Latest:

Crossing the Blood-Brain Barrier: Integrating Scientific Innovation With Socio-Ethical Reflection in Predictive Medicine

In this article, we discuss recent advances in drug transporters and nutrient-transporter interactions that can impact drug bioavailability in the systemic circulation and the brain. We also present emerging research strategies that may facilitate the discovery and clinical development of predictive diagnostic tests to identify patients at risk for treatment resistance.


W. Burleson Daviss, MD

Latest:

Mini Quiz: ADHD Comorbidity

What are the facts regarding co-occurring depression and ADHD?


W. David Lohr, MD

Latest:

Clinical Manual of Couples and Family Therapy

The Clinical Manual of Couples and Family Therapy is a succinct, well-written volume that provides evidence for the wisdom behind treatment of the family and/or involvement of the family when treating the patient.


W. Douglas Evans, PhD

Latest:

Marketing Off-Label Uses: Shady Practices Within a Gray Market

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1


W. J. Richardson Jr, BA, AAS

Latest:

Traditional Healing Concepts and Psychiatry: Collaboration and Integration in Psychiatric Practice

The authors share a model for psychiatrists interested in collaborating with traditional healing and medicine.


W. Michael Caudle, PhD

Latest:

Mini Quiz: Evaluating Biomarkers of Neurotoxicology

A quiz on biological approaches to evaluating biomarkers of neurotoxicity in the psychiatric setting.


W. Vaughn McCall, MD, MS

Latest:

The Correlation Between Sleep Disturbance and Suicide

All psychiatrists know the risk factors for suicide. Among the newest modifiable risk factors to join the list are insomnia and nightmares.


Wadie Najm, MD

Latest:

Using Complementary Treatments

The promise of natural products as possible sources of new treatments for Alzheimer's disease and other dementing illnesses is on the rise. Scientific evidence for the 13 dietary supplements most commonly used for memory impairment is analyzed and evaluated.


Waguih William Ishak, MD

Latest:

Outcome Assessment in Depression

Regular interval administration of outcome measurement tools has proved to be beneficial in improving the quality of care that we all hope to provide for our patients.

© 2024 MJH Life Sciences

All rights reserved.